Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
02/2012
02/29/2012EP2421521A1 Stable topical compositions for 1,2,4-thiadiazole derivatives
02/29/2012EP2421520A1 Pharmaceutical compositions for the treatment of nasal polyposis
02/29/2012EP2421519A1 Blockers of nmda receptor for the treatment of sickle cell anemia
02/29/2012EP2421516A1 Method for improving the dissolution profile of a biologically active material
02/29/2012EP2421515A2 Particulate pharmaceutical composition having an opioid and an opioid antagonist
02/29/2012EP2421514A2 Agglomerate formulations useful in dry powder inhalers
02/29/2012EP2421513A1 A novel formulation of indomethacin
02/29/2012EP2421512A1 A novel formulation of naproxen
02/29/2012EP2421511A1 Method for the production of commercial nanoparticle and microparticle powders
02/29/2012EP2421507A1 Chewing gum and particulate material for controlled release of active ingredients
02/29/2012EP2421504A1 Paediatric solutions comprising a beta-blocker
02/29/2012EP2421503A1 Sublingual pharmaceutical composition comprising a neutral oil
02/29/2012EP2421502A2 Use of glycyrrhetic acid and/or derivatives thereof for the production of cosmetic or dermatological preparations for the prophylaxis of damage to skin dna and/or for repairing previously incurred damaged to skin dna
02/29/2012EP2421373A1 Colon lavage system
02/29/2012EP2421370A1 2-alkyl piperidine mglur5 receptor modulators
02/29/2012EP2421368A1 Compounds, compositions and methods comprising pyridazine sulfonamide derivatives
02/29/2012EP2421367A1 Allantoin administration for the treatment of neurodegenerative disease and neurotrauma
02/29/2012EP2421366A1 Heterocyclic fused cinnoline m1 receptor positive allosteric modulators
02/29/2012EP2421364A1 Use of guanethidine for treating hypertension by local vascular delivery
02/29/2012EP2368989A9 Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis c virus
02/29/2012EP2328866B1 3',6-substituted indirubins and their biological applications
02/29/2012EP2323982B1 Fluorescent regulators of rassf1a expression and human cancer cell proliferation
02/29/2012EP2323980B1 7-(piperazine-1-ymethyl)-1h-indole-2-carboxylic acid (phenyl)-amide derivatives and allied compounds as p38 map kinase inhibitors for the treatment of respiratory diseases
02/29/2012EP2212301B1 An improved process for preparation of letrozole and its intermediates
02/29/2012EP2205569B1 Alkylthio pyrimidines as crth2 antagonists
02/29/2012EP2203447B1 Inhibitors of the interaction between mdm2 and p53
02/29/2012EP2176255B1 Andrographolide derivatives and use thereof in manufacture of medicaments
02/29/2012EP2123649B1 3-pyrrolo-cyclohexylene-2-dihydro-indolinone derivatives and uses thereof
02/29/2012EP2094643B1 N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
02/29/2012EP2049116B1 Hepatitis c virus inhibitors
02/29/2012EP2048948B1 Liquid compositions of calcium acetate
02/29/2012EP2039686B1 Dihydropyrimidine compounds and their uses in preparation of medicaments for treating and preventing antiviral diseases
02/29/2012EP2007429B1 Oral formulation with beneficial cardiovascular effects, comprising berberine
02/29/2012EP1975158B9 Novel pyrrole derivatives with histone deacetylase inhibitor activity
02/29/2012EP1954241B1 Sustained-release formulation of zonisamide
02/29/2012EP1953148B1 Heterocyclic amide compound and use thereof
02/29/2012EP1951718B1 4-oxadiazolyl-piperidine compounds and use thereof
02/29/2012EP1909804B1 Glucosamine and derivatives thereof useful as transglutaminase inhibitors in the treatment of a nervous system disorder
02/29/2012EP1904438B1 Dicycloalkylcarbamoyl ureas as glucokinase activators
02/29/2012EP1871375B1 Carboline derivatives useful in the treatment of cancer
02/29/2012EP1849830B1 Finely divided composition containing poorly water soluble substance
02/29/2012EP1827461B1 Cladribine regimen for treating multiple sclerosis
02/29/2012EP1727883B1 Vegetable based dioxanone derivatives, synthesis and uses thereof
02/29/2012EP1669350B1 Piperidine derivatives
02/29/2012EP1667966B1 N-alkylated diaminopropane derivatives as modulators of chemokine receptor activity
02/29/2012EP1638567B1 Composition comprising a pulmonary surfactant and sildenafil for the treatment of lung diseases
02/29/2012EP1636208B1 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
02/29/2012EP1625850B1 Immunostimulating agents
02/29/2012EP1622860B1 AMINO-PROPANOL DERIVATIVES AS SPHINGOSINE-1-PHOSPHATE RECEPTOR MODULATORs
02/29/2012EP1606248B1 Sulfonic acids, their derivatives and pharmaceutical compositions containing them
02/29/2012EP1542997B1 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents
02/29/2012EP1532153B1 Azepinoindole and pyridoindole derivatives as pharmaceutical agents
02/29/2012EP1480677B1 Composition for stabilizing hyaluronic acid
02/29/2012EP1465642B1 Protection against the neurotoxicity of oxaliplatin through the administration of calcium and magnesium
02/29/2012EP1390383B1 Antisense permeation enhancers
02/29/2012EP1311269B1 Method of using diketopiperazines and composition containing them
02/29/2012EP1248604B2 Combinations comprising dipeptidylpeptidase-iv inhibitors and antidiabetic agents
02/29/2012CN202151439U 一种方便服用的麝香保心丸 A convenient taking HMP
02/29/2012CN1972678B Steroid intraocular implants having an extended sustained release for a period of greater than two months
02/29/2012CN1947747B Traditional Chinese medicine composition containing luteolin and capsule of sweeping forsythia and its preparation method and use
02/29/2012CN1939414B Medicinal composition with antibacterial and anti-inflammation functions
02/29/2012CN1921888B Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
02/29/2012CN102365293A Nucleic Acids Specifically Binding With Human Factor Vii/Viia And Uses Thereof
02/29/2012CN102365290A Method for producing sugar composition containing definite amount of target hexose and having sugar composition ratio different from starting sugar material, and use of sugar composition thus produced
02/29/2012CN102365285A 1-heterocyclyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a modulators
02/29/2012CN102365282A 9H-pyrrolo[2,3-B: 5,4-C'] dipyridine azacarboline derivatives, preparation thereof, and therapeutic use thereof
02/29/2012CN102365281A Indolizine derivative and use thereof for medical purposes
02/29/2012CN102365280A New adenosine receptor ligands and uses thereof
02/29/2012CN102365279A Hydroxy-methyl isoxazole derivatives as gaba a modulators
02/29/2012CN102365277A Inhibitors of jun n-terminal kinase
02/29/2012CN102365276A Substituted spiro-amide compounds
02/29/2012CN102365275A Carboxamide compounds and methods for using the same
02/29/2012CN102365273A Thiadiazole and oxadiazole derivatives, preparation thereof, and therapeutic use thereof
02/29/2012CN102365272A Key intermediates for the synthesis of rosuvastatin or pharmaceutically acceptable salts thereof
02/29/2012CN102365271A Heterocyclic compounds as autotaxin inhibitors
02/29/2012CN102365269A Novel therapeutic agent for cognitive impairment
02/29/2012CN102365265A Indane derivatives
02/29/2012CN102365261A Process for producing carboxylic acid compound
02/29/2012CN102365098A Finely pulverized pharmaceutical composition
02/29/2012CN102365092A Burdock fruit extract containing arctigenin at high content and process for producing same
02/29/2012CN102365088A Pharmaceutical composition for enhancing adiponectin production and food useful therefor
02/29/2012CN102365087A Methods for improving cognitive function and decreasing heart rate
02/29/2012CN102365086A Composition for alleviating ultraviolet radiation-induced damage
02/29/2012CN102365085A Abuse resistant melt extruded formulation having reduced alcohol interaction
02/29/2012CN102365083A Controlled release pharmaceutical composition with resistance against the influence of ethanol employing a coating comprising a polymer mixture and excipients
02/29/2012CN102365024A Compounds, compositions, and methods for preventing metastasis of cancer cells
02/29/2012CN102365023A Methods for treating vascular leak syndrome
02/29/2012CN102365021A Novel benzodiazepine derivatives
02/29/2012CN102365020A Pyridazinone compounds
02/29/2012CN102365017A Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom
02/29/2012CN102363622A Compound and preparation method and use thereof
02/29/2012CN102363621A Cefminox sodium hexahydrate, preparation method thereof and pharmaceutical composition containing hexahydrate
02/29/2012CN102363619A Water soluble protoporphyrin compound and preparation method and use thereof
02/29/2012CN102363618A Novel inhibitor of epidermal growth factor receptor (EGFR) and application thereof
02/29/2012CN102363037A Externally applied plaster for treating rheumatism, rheumatoid arthritis and neck-shoulder and lumbocrural pain
02/29/2012CN102363028A Formula and method for treating and combined diseases of lung channel and heart channel by using traditional Chinese medicine
02/29/2012CN102363016A Traditional Chinese medicine composite dripping core pills and preparation method thereof
02/29/2012CN102363007A Chinese medicinal formula and method for treating spleen channel and lung channel complicating disease
02/29/2012CN102363006A Formula of Chinese medicines and method for treating combined spleen channel and heart channel tissue diseases
02/29/2012CN102362997A Medicine used for treating knee osteoarthritis, and preparation method thereof
1 ... 1334 1335 1336 1337 1338 1339 1340 1341 1342 1343 1344 1345 1346 1347 1348 1349 1350 1351 1352 1353 1354 ... 7860